Characterization of supertypic HLA-C epitopes related to the KIR-ligand dimorphism

被引：0
|
作者：
Fernandez-Vina, M. [1 ]
Cano, P. [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Lab Med, Houston, TX 77030 USA
来源：
TISSUE ANTIGENS | 2007年 / 69卷 / 05期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：383 / 383
页数：1
相关论文
共 50 条
  • [41] The impact of high resolution hla and Kir-ligand mismatches on clinical outcome in unrelated cord blood transplantation
    Creary, L. E.
    BRown, C. J.
    Davey, S.
    Miqueles, G.
    Ionescu, I.
    Ruggeri, A.
    Gluckman, E.
    Rocha, V.
    Navarrete, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S100 - S100
  • [42] Infection related mortality in KIR-ligand mismatch in unrelated allogeneic hematopoetic stem cell transplantation
    Schaffer, M
    Ringdén, O
    Remberger, M
    Ljunggren, HG
    Malmberg, KJ
    GENES AND IMMUNITY, 2005, 6 : S49 - S49
  • [43] THE CHARACTERISTICS OF KIR2DL1 ALLELES POLYMORPHISM AND RECOGNITION HLA-C LIGAND IN THE CHINESE HAN POPULATION
    He, Jun
    Wang, Miao
    Bao, Xiaojing
    Zhang, Jiang
    HUMAN IMMUNOLOGY, 2014, 75 : 92 - 92
  • [44] Role of donor HLA class I mismatch, KIR-ligand mismatch and HLA:KIR pairings in hematological malignancy relapse after unrelated hematopoietic stem cell transplantation
    Graczyk-Pol, Elzbieta
    Rogatko-Koros, Marta
    Nestorowicz, Klaudia
    Gwozdowicz, Slawomir
    Mika-Witkowska, Renata
    Pawliczak, Daria
    Zubala, Marta
    Szlendak, Urszula
    Witkowska, Agnieszka
    Tomaszewska, Agnieszka
    Nasilowska-Adamska, Barbara
    Szczepinski, Andrzej
    Wojcik, Michal
    Halaburda, Kazimierz
    Nowak, Jacek
    HLA, 2018, 92 : 42 - 46
  • [45] Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells
    Sonja Verheyden
    Soldano Ferrone
    Arend Mulder
    Frans H. Claas
    Rik Schots
    Barbara De Moerloose
    Yves Benoit
    Christian Demanet
    Cancer Immunology, Immunotherapy, 2009, 58
  • [46] Improved KIR gene and HLA-C KIR ligand sequence-specific primer polymerase chain reaction genotyping using whole genome amplification
    Chainonthee, W.
    Boettcher, G.
    Gagne, K.
    Fuessel, M.
    Bignon, J. -D.
    Wassmuth, R.
    TISSUE ANTIGENS, 2010, 76 (02): : 135 - 143
  • [47] Susceptibility to Crohn's disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand
    Hollenbach, Jill A.
    Ladner, Martha B.
    Saeteurn, Koy
    Taylor, Kent D.
    Mei, Ling
    Haritunians, Talin
    McGovern, Dermot P. B.
    Erlich, Henry A.
    Rotter, Jerome I.
    Trachtenberg, Elizabeth A.
    IMMUNOGENETICS, 2009, 61 (10) : 663 - 671
  • [48] Susceptibility to Crohn’s disease is mediated by KIR2DL2/KIR2DL3 heterozygosity and the HLA-C ligand
    Jill A. Hollenbach
    Martha B. Ladner
    Koy Saeteurn
    Kent D. Taylor
    Ling Mei
    Talin Haritunians
    Dermot P. B. McGovern
    Henry A. Erlich
    Jerome I. Rotter
    Elizabeth A. Trachtenberg
    Immunogenetics, 2009, 61 : 663 - 671
  • [49] Role of the inhibitory KIR ligand HLA-Bw4 and HLA-C expression levels in the recognition of leukemic cells by Natural Killer cells
    Verheyden, Sonja
    Ferrone, Soldano
    Mulder, Arend
    Claas, Frans H.
    Schots, Rik
    De Moerloose, Barbara
    Benoit, Yves
    Demanet, Christian
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (06) : 855 - 865
  • [50] Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome
    Bishara, Amal
    Brautbar, Chaim
    Zamir, Gideon
    Eid, Ahmed
    Safadi, Rifaat
    HUMAN IMMUNOLOGY, 2005, 66 (11) : 1099 - 1105
12345